pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
elafibranor
Iqirvo (elafibranor)
Primary Sclerosing Cholangitis
Peroxisome proliferator-activated receptor alphaPeroxisome proliferator-activated receptor delta
Ipsen SA
0 catalysts
Marketed
elagolix sodium + estradiol + norethindrone + elagolix sodium
Oriahnn (elagolix sodium + estradiol + norethindrone + elagolix sodium)
Menorrhagia
$ABBVAbbVie Inc.
0 catalysts
Marketed
elapegademase
← prev
page 174 of 231
next →
131
Pain89
Neurology1
Revcovi (elapegademase-lvlr)
Adenosine Deaminase (ADA) Deficiency Related SCID
Leadiant Biosciences Inc
0 catalysts
Marketed
elasomeran
Spikevax (elasomeran [INN])
Coronavirus Disease 2019 (COVID-19)
$MRNAModerna, Inc.
0 catalysts
Phase 3
elebsiran
Hepatitis D
$VIRVir Biotechnology, Inc.
0 catalysts
Phase 3
elebsiran + tobevibart
Hepatitis D
$VIRVir Biotechnology, Inc.
0 catalysts
Phase 2
elecoglipron
Type 2 Diabetes
$AZNASTRAZENECA PLC
0 catalysts
Phase 3
elegrobart
Graves' Ophthalmopathy
Viridian Therapeutics Inc
0 catalysts
Phase 3
elenestinib
Systemic Mastocytosis
Blueprint Medicines Corp
0 catalysts
Preclinical
elesclomol
Endometrial Cancer
Edison Oncology Holding Corp
0 catalysts
Marketed
eletriptan hydrobromide
Eletriptan Hydrobromide (eletriptan hydrobromide)
Migraine
Beximco Pharmaceuticals USA Inc
0 catalysts
Phase 2
elezanumab
Traumatic Spinal Cord Injury
Repulsive guidance molecule A
$ABBVAbbVie Inc.
0 catalysts
Phase 3
elfucose
Inherited Metabolic Disorders
AUG Therapeutics LLC
0 catalysts
Phase 2
elifactant
Neonatal Respiratory Distress Syndrome
Chiesi Farmaceutici SpA
0 catalysts
Marketed
eliglustat tartrate
Eliglustat Tartrate (eliglustat tartrate)
Gaucher Disease Type I
Aizant Drug Research Solutions Pvt Ltd
0 catalysts
Marketed
elinzanetant
Lynkuet (elinzanetant)
Vasomotor Symptoms of Menopause (Hot Flashes)
Bayer USA LLC
0 catalysts
Phase 2
elironrasib
Non-Small Cell Lung Cancer
$RVMDRevolution Medicines, Inc.
0 catalysts
Phase 2
elisrasib
elisrasib [INN]
Solid Tumor
D3 Bio Inc
0 catalysts
Marketed
elivaldogene autotemcel
Skysona (elivaldogene autotemcel [INN])
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Genetix Biotherapeutics Inc
0 catalysts
Marketed
elosulfase alfa
Vimizim (elosulfase alfa)
Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome )
$BMRNBIOMARIN PHARMACEUTICAL INC
0 catalysts
Marketed
elotuzumab
Empliciti (elotuzumab)
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
0 catalysts
Phase 2
elraglusib
Neuroblastoma
Glycogen synthase kinase-3 beta
$ACTUACTUATE THERAPEUTICS, INC.
0 catalysts
Phase 3
elritercept
Anemia
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 3
elsunersen
elsunersen [INN]
Epileptic Encephalopathy
$PRAXPraxis Precision Medicines, Inc.
0 catalysts
Phase 1
eltanolone
eltanolone [INN]
Epilepsy
$LPCNLipocine Inc.
0 catalysts
Phase 2
eltivutabart
eltivutabart [INN]
Pancreatic Ductal Adenocarcinoma
Trishula Therapeutics Inc
0 catalysts
Phase 2
elunetirom
Bipolar I Disorder
Autobahn Therapeutics Inc
0 catalysts
Marketed
eluxadoline
Viberzi (eluxadoline)
Diarrhea
$ABBVAbbVie Inc.
0 catalysts
Phase 2
elzovantinib
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 3
emactuzumab
Tenosynovial Giant Cell Tumor
Macrophage colony-stimulating factor 1 receptor
SynOx Therapeutics Ltd
0 catalysts